A. J. Bauze, Sportsmed, University of Adelaide, Stepney, South Australia, Australia S. Agrawal, Sportsmed, Stepney, South Australia, Australia A. Cuthbert, South Australian Health and Medical Research Institute, North Terrace, Adelaide, South Australia, Australia R. N. de Steiger, Department of Surgery, Epworth Healthcare, University of Melbourne, Richmond, Victoria, Australia, Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, Australia.
Clin Orthop Relat Res. 2019 Jun;477(6):1315-1321. doi: 10.1097/CORR.0000000000000710.
Hooded acetabular liners and head sizes ≥ 32 mm have both shown to have a beneficial effect on the revision rate for dislocation in THA. Experience with noncrosslinked polyethylene (nonXLPE) raised concerns regarding the risk of impingement damage, loosening, and osteolysis with hooded liners; however, the evidence for this in crosslinked polyethylene (XLPE) is inconclusive. The interaction between different femoral head sizes and hooded liners is not well understood, and it is unclear whether hooded XLPE liners have a beneficial effect on overall long-term survivorship.
QUESTIONS/PURPOSES: We analyzed a large national joint registry to ask: (1) Is the use of hooded XLPE liners associated with a reduced revision rate for dislocation compared with nonhooded liners? (2) Is there a difference in the revision rate for aseptic loosening/osteolysis? (3) Is head size associated with any difference in the revision rate between hooded and nonhooded liners?
The Australian Orthopaedic Association National Joint Replacement Registry longitudinally maintains data on all primary and revision joint arthroplasties with nearly 100% capture. We analyzed all conventional primary THAs performed from registry inception in September 1999 until December 31, 2016 in patients with a diagnosis of osteoarthritis who had nonhooded or hooded XLPE bearings in a cementless acetabular shell. The study group included 192,659 THA procedures with XLPE liners, of which 67,904 were nonhooded and 124,755 were hooded. The mean age of patients receiving nonhooded liners was 70 years (range, 11-100 years); 44% were males. This was similar to the patients with hooded liners, who had a mean age of 70 years (range, 16-100 years); 45% were males. The main outcome measure was the cumulative percent revision at 15 years of the THA using Kaplan-Meier estimates of survivorship. We examined reasons for revision and and performed multivariable analysis to control for the confounding factors of three head size groups (< 32mm, 32mm, and > 32mm) and for the method of femoral fixation.
There was a higher revision rate for dislocation for patients with nonhooded liners at all times to 15 years (HR, 1.31; 95% CI, 1.17-1.47; p < 0.001). There was a higher revision rate for the diagnosis of aseptic loosening/osteolysis with patients with nonhooded liners compared with hooded liners (HR, 1.19; 95% CI, 1.05-1.34; p = 0.006). Head sizes of 32 mm or larger were independently associated with a lower comparative revision rate between hooded and nonhooded liners, but this was not apparent for head sizes smaller than 32 mm. It appeared that the main driver of the finding in larger heads was a reduced dislocation risk with hooded liners for 32 mm heads (HR, 1.50; 95% CI, 1.23-1.80; p < 0.001) and for heads larger than 32 mm (HR, 1.50; 95% CI, 1.20-1.89; p < 0.001).
Prior research has suggested that hooded acetabular liners may be associated with impingement, loosening, and osteolysis; however, in this large, registry-based report we found that XLPE hooded liners are not associated with an increased revision rate for aseptic loosening/osteolysis. Although there are many potential confounding variables in this registry analysis, if anything, surgeons using larger femoral heads and hooded liners likely did so in patients with a higher perceived dislocation risk. Patients with larger heads and XLPE hooded liners were, however, less likely to experience revision for dislocation. These liners therefore appear reasonable to use in primary THA at the surgeon's discretion.
Level III, therapeutic study.
带帽髋臼衬垫和直径≥32mm 的股骨头已被证明可降低全髋关节置换术后脱位的翻修率。使用非交联聚乙烯(非 XLPE)引起了对带帽衬垫撞击损伤、松动和溶骨风险的担忧;然而,交联聚乙烯(XLPE)的证据尚无定论。不同股骨头大小和带帽衬垫之间的相互作用尚不清楚,也不清楚 XLPE 带帽衬垫是否对整体长期生存率有有益的影响。
问题/目的:我们分析了一个大型国家关节登记处,以询问:(1)与非带帽衬垫相比,使用 XLPE 带帽衬垫是否可降低脱位的翻修率?(2)在无菌性松动/溶骨方面,翻修率是否存在差异?(3)股骨头大小与带帽和非带帽衬垫之间的翻修率差异是否有关?
澳大利亚矫形协会国家关节置换登记处从 1999 年 9 月注册开始,一直纵向保存所有初次和翻修关节置换术的数据,几乎 100%的覆盖率。我们分析了所有在诊断为骨关节炎的患者中进行的常规初次全髋关节置换术,这些患者在无骨水泥髋臼壳中使用非 XLPE 或 XLPE 轴承。研究组包括 192659 例接受 XLPE 衬垫的初次全髋关节置换术,其中 67904 例为非带帽,124755 例为带帽。接受非带帽衬垫的患者平均年龄为 70 岁(范围,11-100 岁);44%为男性。这与接受带帽衬垫的患者相似,他们的平均年龄为 70 岁(范围,16-100 岁);45%为男性。主要观察指标是使用 Kaplan-Meier 生存估计的 15 年全髋关节置换术的累积翻修率。我们检查了翻修的原因,并进行了多变量分析,以控制三个股骨头大小组(<32mm、32mm 和>32mm)和股骨固定方法的混杂因素。
在所有时间点到 15 年,非带帽衬垫的患者脱位翻修率更高(HR,1.31;95%CI,1.17-1.47;p<0.001)。与带帽衬垫相比,非带帽衬垫的患者无菌性松动/溶骨的翻修率更高(HR,1.19;95%CI,1.05-1.34;p=0.006)。直径为 32mm 或更大的股骨头大小与带帽和非带帽衬垫之间的比较翻修率降低独立相关,但对于直径小于 32mm 的股骨头大小则不明显。对于较大的股骨头,带帽衬垫降低脱位风险似乎是导致发现的主要因素,对于 32mm 直径的股骨头(HR,1.50;95%CI,1.23-1.80;p<0.001)和直径大于 32mm 的股骨头(HR,1.50;95%CI,1.20-1.89;p<0.001)也是如此。
先前的研究表明带帽髋臼衬垫可能与撞击、松动和溶骨有关;然而,在这项基于大型注册处的报告中,我们发现 XLPE 带帽衬垫与无菌性松动/溶骨的翻修率增加无关。尽管在这个注册表分析中有许多潜在的混杂变量,但如果有的话,使用较大股骨头和带帽衬垫的外科医生可能是在那些脱位风险较高的患者中使用。然而,对于直径较大和 XLPE 带帽衬垫的患者,脱位翻修的可能性较小。因此,这些衬垫在外科医生的酌情决定下,在初次全髋关节置换术中使用是合理的。
III 级,治疗性研究。